Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Venous Thrombosis

Free Subscription Articles published in Thromb Haemost Retrieve available abstracts of 98 articles: HTML format

Single Articles

July 2022
1. GUNER A, Kahraman S, Erturk M
   Does Fibrinolytic Strategy of Pulmonary Embolism International THrOmbolysis (PEITHO)-3 Trial Need More Strong Evidence?
   Thromb Haemost. 2022 Jul 12. doi: 10.1055/a-1897-7141.
   PubMed     Abstract available
   
   
   
2. GOROG DA, Gue YX, Chao TF, Fauchier L, et al
   Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.
   Thromb Haemost. 2022 Jul 6. doi: 10.1055/s-0042-1750385.
   PubMed     Abstract available
   
   
   June 2022
3. MA Z, Sun X, Zhang Y, Li H, et al
   Risk of Thromboembolic Events in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-analysis of Randomized Controlled Trials.
   Thromb Haemost. 2022 Jun 30. doi: 10.1055/s-0042-1749185.
   PubMed     Abstract available
   
   
   
4. KIM SA, Lee JH, Lee JY, Hwang HG, et al
   Treatment and bleeding complications of cancer-associated venous thromboembolism: A Korean population-based study.
   Thromb Haemost. 2022 Jun 28. doi: 10.1055/a-1886-5991.
   PubMed     Abstract available
   
   
   
5. NOUMEGNI SR, Mansourati V, Tromeur C, Mao RL, et al
   Risk Factors of Cardiovascular Death after Venous Thromboembolism: Results from a Prospective Cohort Study.
   Thromb Haemost. 2022 Jun 18. doi: 10.1055/s-0042-1748889.
   PubMed     Abstract available
   
   
   May 2022
6. ZHANG YJ, Li ZH, Shen D, Zhang PD, et al
   Association of Combined Lifestyle and Polygenetic Risk with Incidence of Venous Thromboembolism: A Large Population-Based Cohort Study.
   Thromb Haemost. 2022 May 27. doi: 10.1055/s-0042-1744377.
   PubMed     Abstract available
   
   
   
7. JAKOBSEN L, Frischmuth T, Braekkan SK, Hansen JB, et al
   Joint effect of multiple prothrombotic genotypes and mean platelet volume on the risk of incident venous thromboembolism.
   Thromb Haemost. 2022 May 26. doi: 10.1055/a-1863-2052.
   PubMed     Abstract available
   
   
   April 2022
8. GRIS JR, Bouguignon C, Bouvier S, Cochery-Nouvellon E, et al
   PREGNANCY AFTER COMBINED ORAL CONTRACEPTIVE-ASSOCIATED VENOUS THROMBOEMBOLISM: AN INTERNATIONAL RETROSPECTIVE STUDY OF OUTCOMES.
   Thromb Haemost. 2022 Apr 26. doi: 10.1055/a-1835-8808.
   PubMed     Abstract available
   
   
   
9. D'APOLITO M, Ariano A, D'Andrea G, Tiscia G, et al
   Identification of the novel G250R variant indicates a role for Thrombomodulin in modulating the risk for venous thromboembolism.
   Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7109.
   PubMed     Abstract available
   
   
   
10. NOPP S, Pabinger I
    Growth Differentiation Factor-15: a Novel Biomarker for Predicting Risk of Venous Thromboembolism and Bleeding in Patients with Cancer.
    Thromb Haemost. 2022 Apr 18. doi: 10.1055/a-1827-7328.
    PubMed     Abstract available
    
    
    March 2022
11. GABET A, Grave C, Tuppin P, Olie V, et al
    One Year Prevalence of Venous Thromboembolism in Hospitalized COVID-19 Patients in France: Patients' Characteristics, Time Trends, and Outcomes.
    Thromb Haemost. 2022 Mar 14. doi: 10.1055/s-0042-1743475.
    PubMed     Abstract available
    
    
    
12. ROY DC, Wang TF, Mallick R, Carrier M, et al
    GDF-15, hs-TnT and NT proBNP for Predicting Risk of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy.
    Thromb Haemost. 2022 Mar 9. doi: 10.1055/a-1792-7720.
    PubMed     Abstract available
    
    
    February 2022
13. GOLDIN M, Koulas I, Weitz JI, Spyropoulos A, et al
    State-of-the-art-mini review: Dual pathway inhibition to reduce arterial and venous thromboembolism.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1778-1083.
    PubMed     Abstract available
    
    
    
14. LECUMBERRI R, Ruiz-Artacho P, Tzoran I, Brenner B, et al
    Outcome of cancer-associated venous thromboembolism is more favorable among patients with hematologic malignancies than in those with solid tumors.
    Thromb Haemost. 2022 Feb 21. doi: 10.1055/a-1777-4006.
    PubMed     Abstract available
    
    
    
15. PLANQUETTE B, Khider L, Le Berre A, Soudet S, et al
    Adjusting D-dimer to lung disease extent to exclude Pulmonary Embolism in COVID-19 patients (Co-LEAD).
    Thromb Haemost. 2022 Feb 10. doi: 10.1055/a-1768-4371.
    PubMed     Abstract available
    
    
    January 2022
16. RIVAS A, Lauw MN, Bonin-Schnabel R, Crowther M, et al
    Stroke and Thromboembolism in Patients with Heart Failure and Sinus Rhythm: A Matter of Risk Stratification?
    Thromb Haemost. 2022 Jan 19. doi: 10.1055/a-1745-2083.
    PubMed     Abstract available
    
    
    
17. CHEONG MA, Chew KM
    All that clots is not blood: Bone cement implantation syndrome presenting as an intracardiac mass and pulmonary embolism.
    Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1777.
    PubMed     Abstract available
    
    
    
18. BERTOLETTI L, Gusto G, Khachatryan A, Quignot N, et al
    Effectiveness and safety of oral anticoagulants in the treatment of acute venous thromboembolism: A nationwide comparative cohort study in France.
    Thromb Haemost. 2022 Jan 4. doi: 10.1055/a-1731-3922.
    PubMed     Abstract available
    
    
    December 2021
19. FLORIN J, Stalder O, Baumgartner C, Mean M, et al
    Do Patients with a Family or Personal History of Venous Thromboembolism have an Increased Risk of Recurrence?
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740184.
    PubMed     Abstract available
    
    
    
20. COHEN AT, Sah J, Dhamane AD, Lee T, et al
    Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
    Thromb Haemost. 2021 Dec 28. doi: 10.1055/s-0041-1740254.
    PubMed     Abstract available
    
    
    
21. DUBOIS-SILVA A, Barbagelata-Lopez C, Pineiro-Parga P, Francisco I, et al
    Prognostic Significance of Concomitant Superficial Vein Thrombosis in Patients with Deep Vein Thrombosis of the Lower Limbs.
    Thromb Haemost. 2021;121:1650-1659.
    PubMed     Abstract available
    
    
    November 2021
22. ROTHBERG MB, Hamilton A, Greene MT, Fox J, et al
    Derivation and Validation of a Risk Factor Model to Identify Medical Inpatients at Risk for Venous Thromboembolism.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6506.
    PubMed     Abstract available
    
    
    
23. EVENSEN LH, Arnesen CAL, Rosendaal FR, Gabrielsen ME, et al
    The risk of venous thromboembolism attributed to established prothrombotic genotypes.
    Thromb Haemost. 2021 Nov 16. doi: 10.1055/a-1698-6717.
    PubMed     Abstract available
    
    
    
24. ZHOU C, Yi Q, Ge H, Wei H, et al
    Validation of risk assessment models predicting venous thromboembolism in inpatients with AECOPD: a multicenter cohort study.
    Thromb Haemost. 2021 Nov 10. doi: 10.1055/a-1693-0063.
    PubMed     Abstract available
    
    
    
25. KHAN F, Rahman A, Tritschler T, Carrier M, et al
    Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis.
    Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
    PubMed     Abstract available
    
    
    September 2021
26. SANCHEZ O, Charles-Nelson A, Ageno W, Barco S, et al
    Reduced-dose intravenous thrombolysis for acute intermediate high-risk pulmonary embolism: Rationale and design of the PEITHO-3 trial.
    Thromb Haemost. 2021 Sep 24. doi: 10.1055/a-1653-4699.
    PubMed     Abstract available
    
    
    
27. SHARMAN MOSER S, Chodick G, Ni YG, Chalothorn D, et al
    The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events.
    Thromb Haemost. 2021 Sep 23. doi: 10.1055/s-0041-1735971.
    PubMed     Abstract available
    
    
    
28. MAHE I, Agnelli G, Ay C, Bamias A, et al
    Extended Anticoagulant Treatment with Full- or Reduced-Dose Apixaban in Patients with Cancer-Associated Venous Thromboembolism: the API-CAT Study.
    Thromb Haemost. 2021 Sep 17. doi: 10.1055/a-1647-9896.
    PubMed     Abstract available
    
    
    
29. AGNELLI G, Munoz A, Franco L, Mahe I, et al
    Apixaban and Dalteparin for the Treatment of Venous Thromboembolism in Patients with Different Sites of Cancer.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/s-0041-1735194.
    PubMed     Abstract available
    
    
    
30. BIKDELI B, Hogan H, Morrison R, Fanikos J, et al
    Extended-Duration Low-intensity Apixaban to Prevent Recurrence in Patients with Provoked Venous Thromboembolism: Design of the HI-PRO Trial.
    Thromb Haemost. 2021 Sep 16. doi: 10.1055/a-1646-2244.
    PubMed     Abstract available
    
    
    August 2021
31. GABARIN N, Patterson S, Pai M, Afzaal T, et al
    Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
    Thromb Haemost. 2021 Aug 12. doi: 10.1055/a-1585-6182.
    PubMed     Abstract available
    
    
    July 2021
32. VALERIO L, Fedeli U, Schievano E, Avossa F, et al
    Decline in overall pulmonary embolism-related mortality and increasing prevalence of cancer-associated events in the Veneto region (Italy), 2008-2019.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4948.
    PubMed     Abstract available
    
    
    
33. RIEDL JM, Schwarzenbacher E, Moik F, Horvath L, et al
    Patterns of thromboembolism in patients with advanced pancreatic cancer undergoing 1st-line chemotherapy with FOLFIRINOX or Gemcitabine/nab-paclitaxel.
    Thromb Haemost. 2021 Jul 12. doi: 10.1055/a-1548-4847.
    PubMed     Abstract available
    
    
    
34. NOUMEGNI SR, Hoffmann C, Tromeur C, Didier R, et al
    Risk Factors of Arterial Events in Patients with Venous Thromboembolism: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732300.
    PubMed     Abstract available
    
    
    
35. FRISCHMUTH T, Hindberg K, Aukrust P, Ueland T, et al
    Plasma Levels of Leptin and Risk of Future Incident Venous Thromboembolism.
    Thromb Haemost. 2021 Jul 11. doi: 10.1055/s-0041-1732295.
    PubMed     Abstract available
    
    
    June 2021
36. VAN DE BRUG A, De Winter M, Ten Wolde M, Kaasjager K, et al
    Deciding on treatment duration for unprovoked venous thromboembolism: what is important to patients?
    Thromb Haemost. 2021 Jun 24. doi: 10.1055/a-1535-8726.
    PubMed     Abstract available
    
    
    
37. BONNESEN K, Schmidt M, Horvath-Puho E, Sorensen HT, et al
    The interaction effect between comorbidity and venous thromboembolism on mortality rates after venous thromboembolism: A 5-year cohort study.
    Thromb Haemost. 2021 Jun 11. doi: 10.1055/a-1527-6215.
    PubMed     Abstract available
    
    
    
38. MORA D, Nieto JA, Mateo J, Bikdeli B, et al
    Machine learning to predict outcomes in patients with acute pulmonary embolism who prematurely discontinued anticoagulant therapy.
    Thromb Haemost. 2021 Jun 9. doi: 10.1055/a-1525-7220.
    PubMed     Abstract available
    
    
    May 2021
39. HENDRIKS S, Bistervels I, Eijsvogel M, Faber L, et al
    Home treatment compared to initial hospitalization in patients with acute pulmonary embolism in the Netherlands: a cost analysis.
    Thromb Haemost. 2021 May 26. doi: 10.1055/a-1518-1847.
    PubMed     Abstract available
    
    
    
40. FRISCHMUTH T, Hindberg K, Gabrielsen ME, Brumpton BM, et al
    Joint effect of multiple prothrombotic genotypes and obesity on the risk of incident venous thromboembolism.
    Thromb Haemost. 2021 May 3. doi: 10.1055/a-1497-9777.
    PubMed     Abstract available
    
    
    April 2021
41. FREI AN, Stalder O, Limacher A, Mean M, et al
    Comparison of Bleeding Risk Scores in Elderly Patients Receiving Extended Anticoagulation with Vitamin K Antagonists for Venous Thromboembolism.
    Thromb Haemost. 2021 Apr 30. doi: 10.1055/s-0041-1726345.
    PubMed     Abstract available
    
    
    
42. PASTORI D, Agnelli G
    Risk Scores for Death in Patients with Cancer-related Venous Thromboembolism: Still a Long Road Ahead.
    Thromb Haemost. 2021 Apr 22. doi: 10.1055/s-0041-1727244.
    PubMed    
    
    
    
43. GIRARD P, Laporte S, Chapelle C, Falvo N, et al
    Failure of the Ottawa Score to Predict the Risk of Recurrent Venous Thromboembolism in Cancer Patients: The Prospective PREDICARE Cohort Study.
    Thromb Haemost. 2021 Apr 20. doi: 10.1055/a-1486-7497.
    PubMed     Abstract available
    
    
    
44. MOOR J, Baumgartner C, Mean M, Stalder O, et al
    Validation of the 2019 European Society of Cardiology risk stratification algorithm for pulmonary embolism in normotensive elderly patients.
    Thromb Haemost. 2021 Apr 6. doi: 10.1055/a-1475-2263.
    PubMed     Abstract available
    
    
    February 2021
45. HOSKIN S, Brieger D, Chow V, Kritharides L, et al
    Trends in Acute Pulmonary Embolism Admission Rates and Mortality Outcomes in Australia, 2002-2003 to 2017-2018: A Retrospective Cohort Study.
    Thromb Haemost. 2021 Feb 28. doi: 10.1055/s-0041-1725932.
    PubMed     Abstract available
    
    
    
46. HERRERA-RIVERO M, Stoll M, Hegenbarth JC, Ruhle F, et al
    Single- and Multimarker Genome-Wide Scans Evidence Novel Genetic Risk Modifiers for Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 16. doi: 10.1055/s-0041-1723988.
    PubMed     Abstract available
    
    
    
47. KING A, Leider H, Herman D, Malinowski AK, et al
    Patient- and Health-Care-Provider-Reported Outcomes to Consider in Research on Pregnancy-Associated Venous Thromboembolism.
    Thromb Haemost. 2021 Feb 10. doi: 10.1055/s-0041-1722855.
    PubMed     Abstract available
    
    
    
48. KUCZMIK W, Wysokinski WE, Hesley GK, Vlazny DT, et al
    Calf Vein Thrombosis Comparison of Outcomes for Axial and Muscular Venous Thrombosis.
    Thromb Haemost. 2021;121:216-223.
    PubMed     Abstract available
    
    
    January 2021
49. COHEN SL, Gianos E, Barish MA, Chatterjee S, et al
    Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients.
    Thromb Haemost. 2021 Jan 20. doi: 10.1055/a-1366-9656.
    PubMed     Abstract available
    
    
    
50. LI XQ, Hu YH, Lin P, Zhang JR, et al
    Comparison of Different Clinical Prognostic Scores in Patients with Pulmonary Embolism and Active Cancer.
    Thromb Haemost. 2021 Jan 15. doi: 10.1055/a-1355-3549.
    PubMed     Abstract available
    
    
    
51. ORIONE C, Tromeur C, Le Mao R, Le Floch PY, et al
    The Impact of Pulmonary Vascular Obstruction on the Risk of Recurrence of Pulmonary Embolism: A French Prospective Cohort.
    Thromb Haemost. 2021 Jan 14. doi: 10.1055/s-0040-1722190.
    PubMed     Abstract available
    
    
    
52. WENDELBOE AM, Campbell J, Ding K, Bratzler DW, et al
    Incidence of Venous Thromboembolism in a Racially Diverse Population of Oklahoma County, Oklahoma.
    Thromb Haemost. 2021 Jan 10. doi: 10.1055/s-0040-1722189.
    PubMed     Abstract available
    
    
    December 2020
53. LE MAO R, Jimenez D, Bikdeli B, Porres-Aguilar M, et al
    Prognostic Impact of Obstructive Sleep Apnea in Patients Presenting with Acute Symptomatic Pulmonary Embolism.
    Thromb Haemost. 2020 Dec 30. doi: 10.1055/s-0040-1721506.
    PubMed     Abstract available
    
    
    
54. ELIAS A, Aronson D
    Risk of Acute Kidney Injury after Intravenous Contrast Media Administration in Patients with Suspected Pulmonary Embolism: A Propensity-Matched Study.
    Thromb Haemost. 2020 Dec 10. doi: 10.1055/s-0040-1721387.
    PubMed     Abstract available
    
    
    
55. PROIETTI M, Rivera-Caravaca JM, Esteve-Pastor MA, Marin F, et al
    Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
    Thromb Haemost. 2020 Dec 9. doi: 10.1055/a-1333-4448.
    PubMed     Abstract available
    
    
    November 2020
56. ZOLLER BA, Svensson P, Huang W, Ji J, et al
    Reactome pathway analysis of venous thromboembolism, peripheral artery disease, stroke, and coronary artery.
    Thromb Haemost. 2020 Nov 19. doi: 10.1055/a-1315-2307.
    PubMed     Abstract available
    
    
    
57. SPIRK D, Sebastian T, Barco S, Banyai M, et al
    Clinical Outcomes of Incidental Venous Thromboembolism in Cancer and Noncancer Patients: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720977.
    PubMed     Abstract available
    
    
    
58. AGENO W, Vedovati MC, Cohen A, Huisman M, et al
    Bleeding with Apixaban and Dalteparin in Patients with Cancer-Associated Venous Thromboembolism: Results from the Caravaggio Study.
    Thromb Haemost. 2020 Nov 17. doi: 10.1055/s-0040-1720975.
    PubMed     Abstract available
    
    
    
59. ZABCZYK M, Natorska J, Janion-Sadowska A, Metzgier-Gumiela A, et al
    Loose Fibrin Clot Structure and Increased Susceptibility to Lysis Characterize Patients with Central Acute Pulmonary Embolism: The Impact of Isolated Embolism.
    Thromb Haemost. 2020 Nov 13. doi: 10.1055/s-0040-1718762.
    PubMed     Abstract available
    
    
    
60. COHEN A, Keshishian A, Lee T, Wygant G, et al
    Effectiveness and Safety of Apixaban, Low-Molecular-Weight Heparin, and Warfarin among Venous Thromboembolism Patients with Active Cancer: A U.S. Claims Data Analysis.
    Thromb Haemost. 2020 Nov 10. doi: 10.1055/s-0040-1718728.
    PubMed     Abstract available
    
    
    October 2020
61. SCHULMAN S, Hu Y, Konstantinides S
    Venous Thromboembolism in COVID-19.
    Thromb Haemost. 2020 Oct 24. doi: 10.1055/s-0040-1718532.
    PubMed     Abstract available
    
    
    September 2020
62. PICKER N, Lee AY, Cohen AT, Maraveyas A, et al
    Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study).
    Thromb Haemost. 2020 Sep 2. doi: 10.1055/s-0040-1714739.
    PubMed     Abstract available
    
    
    August 2020
63. XIN L, Sun S, Wang J, Lu W, et al
    Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials.
    Thromb Haemost. 2020 Aug 9. doi: 10.1055/s-0040-1715444.
    PubMed    
    
    
    July 2020
64. ELGENDY IY, Fogerty A, Blanco-Molina A, Rosa V, et al
    Clinical Characteristics and Outcomes of Women Presenting with Venous Thromboembolism during Pregnancy and Postpartum Period: Findings from the RIETE Registry.
    Thromb Haemost. 2020 Jul 27. doi: 10.1055/s-0040-1714211.
    PubMed     Abstract available
    
    
    
65. LEE JK, Chen WH, Lin YS, Chang CH, et al
    Comparison of Effectiveness between Anticoagulation and Thrombolysis Therapy for Pulmonary Embolism in Patients Complicated with Shock: A Nationwide Population-Based Study.
    Thromb Haemost. 2020 Jul 17. doi: 10.1055/s-0040-1713095.
    PubMed     Abstract available
    
    
    June 2020
66. HENDRIKS SV, den Exter PL, Zondag W, Brouwer R, et al
    Reasons for Hospitalization of Patients with Acute Pulmonary Embolism Based on the Hestia Decision Rule.
    Thromb Haemost. 2020 Jun 28. doi: 10.1055/s-0040-1713170.
    PubMed     Abstract available
    
    
    
67. WANG D, Fan G, Liu X, Wu S, et al
    Renal Insufficiency and Short-Term Outcomes of Acute Pulmonary Embolism: A Systemic Review and Meta-Analysis.
    Thromb Haemost. 2020 Jun 11. doi: 10.1055/s-0040-1712459.
    PubMed     Abstract available
    
    
    
68. SCHULMAN S, Konstantinides S, Hu Y, Tang LV, et al
    Venous Thromboembolic Diseases: Diagnosis, Management and Thrombophilia Testing: Observations on NICE Guideline [NG158].
    Thromb Haemost. 2020 Jun 11. doi: 10.1055/s-0040-1712913.
    PubMed    
    
    
    
69. SPYROPOULOS AC, Ageno W, Cohen AT, Gibson CM, et al
    Prevention of Venous Thromboembolism in Hospitalized Medically Ill Patients: A U.S. Perspective.
    Thromb Haemost. 2020;120:924-936.
    PubMed     Abstract available
    
    
    
70. BAVALIA R, Middeldorp S, Weisser G, Espinola-Klein C, et al
    Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants.
    Thromb Haemost. 2020;120:899-911.
    PubMed     Abstract available
    
    
    May 2020
71. QUEZADA A, Jimenez D, Bikdeli B, Muriel A, et al
    Outcomes after Vena Cava Filter Use in Patients with Cancer-Associated Venous Thromboembolism and Contraindications to Anticoagulation.
    Thromb Haemost. 2020 May 18. doi: 10.1055/s-0040-1710589.
    PubMed     Abstract available
    
    
    
72. GIUSTOZZI M, Agnelli G, Del Toro-Cervera J, Klok FA, et al
    Direct Oral Anticoagulants for the Treatment of Acute Venous Thromboembolism Associated with Cancer: A Systematic Review and Meta-Analysis.
    Thromb Haemost. 2020 May 4. doi: 10.1055/s-0040-1712098.
    PubMed     Abstract available
    
    
    
73. GIUSTOZZI M, Curcio A, Weijs B, Field TS, et al
    Variation in the Association between Antineoplastic Therapies and Venous Thromboembolism in Patients with Active Cancer.
    Thromb Haemost. 2020;120:847-856.
    PubMed     Abstract available
    
    
    
74. BETENSKY M, Mueller MG, Amankwah EK, Goldenberg NA, et al
    In Children with Provoked Venous Thromboembolism, Increasing Plasma Coagulability during the First 3 Months Postdiagnosis is Prognostic of Recurrence.
    Thromb Haemost. 2020;120:823-831.
    PubMed     Abstract available
    
    
    
75. ALBERTSEN IE, Sogaard M, Goldhaber SZ, Piazza G, et al
    Development of Sex-Stratified Prediction Models for Recurrent Venous Thromboembolism: A Danish Nationwide Cohort Study.
    Thromb Haemost. 2020;120:805-814.
    PubMed     Abstract available
    
    
    
76. XU K, Chan NC
    Refining Risk Prediction for Recurrent Venous Thromboembolism: Can We Do Better?
    Thromb Haemost. 2020;120:725-727.
    PubMed    
    
    
    April 2020
77. CATTANEO M, Bertinato EM, Birocchi S, Brizio C, et al
    Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified?
    Thromb Haemost. 2020 Apr 29. doi: 10.1055/s-0040-1712097.
    PubMed    
    
    
    
78. ZHAI Z, Li C, Chen Y, Gerotziafas G, et al
    Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
    Thromb Haemost. 2020 Apr 21. doi: 10.1055/s-0040-1710019.
    PubMed     Abstract available
    
    
    
79. BARCO S, Konstantinides SV
    Predicting Venous Thromboembolism in Primary Care.
    Thromb Haemost. 2020;120:531-533.
    PubMed    
    
    
    
80. ABDULLA A, Davis WM, Ratnaweera N, Szefer E, et al
    A Meta-Analysis of Case Fatality Rates of Recurrent Venous Thromboembolism and Major Bleeding in Patients with Cancer.
    Thromb Haemost. 2020;120:702-713.
    PubMed     Abstract available
    
    
    
81. DENTALI F, Fontanella A, Cohen AT, Simonetti M, et al
    Derivation and Validation of a Prediction Model for Venous Thromboembolism in Primary Care.
    Thromb Haemost. 2020;120:692-701.
    PubMed     Abstract available
    
    
    
82. MARCHENA PJ, Tzoran I, Brenner B, Martin M, et al
    Psychotropic Drugs and Outcome in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism.
    Thromb Haemost. 2020;120:620-626.
    PubMed     Abstract available
    
    
    February 2020
83. WEI WT, Liu PP, Lin SM, Peng CC, et al
    Hypothyroidism and the Risk of Venous Thromboembolism: A Nationwide Cohort Study.
    Thromb Haemost. 2020 Feb 6. doi: 10.1055/s-0039-3402761.
    PubMed     Abstract available
    
    
    
84. KOOPMANS RJ, Cannegieter SC, Koot RW, Vleggeert-Lankamp CLA, et al
    Nadroparin Plus Compression Stockings versus Nadroparin Alone for Prevention of Venous Thromboembolism in Cerebellopontine Angle Tumour Excisions: A Cohort Study.
    Thromb Haemost. 2020 Feb 6. doi: 10.1055/s-0039-3402732.
    PubMed     Abstract available
    
    
    January 2020
85. WEYCKER D, Li X, Wygant GD, Lee T, et al
    Erratum: Effectiveness and Safety of Apixaban versus Warfarin as Outpatient Treatment of Venous Thromboembolism in U.S. Clinical Practice.
    Thromb Haemost. 2020 Jan 27. doi: 10.1055/s-0039-3400530.
    PubMed    
    
    
    
86. HARENBERG J, Verhamme P
    The Dangerous Liaisons between Chronic Obstructive Pulmonary Disease and Venous Thromboembolism.
    Thromb Haemost. 2020 Jan 23. doi: 10.1055/s-0039-1701012.
    PubMed    
    
    
    
87. WALDEN K, Jeppsson A, Nasic S, Karlsson M, et al
    Fibrinogen Concentrate to Cardiac Surgery Patients with Ongoing Bleeding does not Increase the Risk of Thromboembolic Complications or Death.
    Thromb Haemost. 2020 Jan 15. doi: 10.1055/s-0039-3402759.
    PubMed     Abstract available
    
    
    
88. AL-ANI F, Wang YP, Lazo-Langner A
    Development of a Clinical Prediction Rule for Venous Thromboembolism in Patients with Acute Leukemia.
    Thromb Haemost. 2020 Jan 1. doi: 10.1055/s-0039-3400303.
    PubMed     Abstract available
    
    
    December 2019
89. BORVIK T, Braekkan SK, Evensen LH, Brodin EE, et al
    Chronic Obstructive Pulmonary Disease and Risk of Mortality in Patients with Venous Thromboembolism-The Tromso Study.
    Thromb Haemost. 2019 Dec 30. doi: 10.1055/s-0039-3400744.
    PubMed     Abstract available
    
    
    
90. SCHINDEWOLF M, Weitz JI
    Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment.
    Thromb Haemost. 2019 Dec 13. doi: 10.1055/s-0039-3400302.
    PubMed     Abstract available
    
    
    November 2019
91. PELARGOS PE, Dunn IF
    Venous Thromboembolism Prophylaxis: Safe, but Still Provocative?
    Thromb Haemost. 2019;119:1716-1718.
    PubMed    
    
    
    
92. KHORANA AA
    Modeling Complexity: The Case of Cancer-Related Venous Thromboembolism.
    Thromb Haemost. 2019;119:1713-1715.
    PubMed    
    
    
    October 2019
93. ISAKSEN T, Evensen LH, Braekkan SK, Hansen JB, et al
    Dietary Intake of Marine Polyunsaturated n-3 Fatty Acids and Risk of Recurrent Venous Thromboembolism.
    Thromb Haemost. 2019 Oct 28. doi: 10.1055/s-0039-1697663.
    PubMed     Abstract available
    
    
    
94. LIN SY, Chang YL, Yeh HC, Lin CL, et al
    Blood Transfusion and Risk of Venous Thromboembolism: A Population-Based Cohort Study.
    Thromb Haemost. 2019 Oct 22. doi: 10.1055/s-0039-1697664.
    PubMed     Abstract available
    
    
    
95. SQUIZZATO A, Agnelli G, Campanini M, Dentali F, et al
    Prophylaxis of Venous Thromboembolism after Hospital Discharge in Internal Medicine: Findings from the Observational FADOI-NoTEVole Study.
    Thromb Haemost. 2019 Oct 21. doi: 10.1055/s-0039-1697661.
    PubMed     Abstract available
    
    
    
96. PETERSEN PB, Jorgensen CC, Kehlet H
    Venous Thromboembolism despite Ongoing Prophylaxis after Fast-Track Hip and Knee Arthroplasty: A Prospective Multicenter Study of 34,397 Procedures.
    Thromb Haemost. 2019 Oct 6. doi: 10.1055/s-0039-1696686.
    PubMed     Abstract available
    
    
    
97. ERICKSON RM, Feehan M, Munger MA, Tak C, et al
    Understanding Factors Associated with Quality of Life in Patients with Venous Thromboembolism.
    Thromb Haemost. 2019 Oct 6. doi: 10.1055/s-0039-1696717.
    PubMed     Abstract available
    
    
    
98. SCHELLONG SM, Goldhaber SZ, Weitz JI, Ageno W, et al
    Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry.
    Thromb Haemost. 2019;19:1675-1685.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Venous Thrombosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: